Back to top
more

CORE LABS INC (CLB)

(Real Time Quote from BATS)

$10.47 USD

10.47
661,314

+0.18 (1.75%)

Updated Aug 7, 2025 09:48 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 8% (227 out of 246)

Industry: Oil and Gas - Field Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Core Labs (CLB) Reveals Plans to Transfer Domicile to U.S.

by Zacks Equity Research

Core Labs plans to relocate from the Netherlands to the United States to increase shareholder value over time by streamlining its corporate structure, enhancing operational effectiveness and reducing cost.

Zacks Equity Research

SLB or CLB: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

Zacks Equity Research

Core Laboratories (CLB) Up 9.6% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

by Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

Zacks Equity Research

Core Labs (CLB) Q3 Earnings Surpass Estimates, Sales Meet

by Zacks Equity Research

Core Labs' (CLB) third-quarter earnings beat the consensus mark, while revenues meet the same.

Zacks Equity Research

Eni (E) Scheduled to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Higher commodity prices are likely to have been favorable for Eni's (E) exploration and production operations in Q3.

Zacks Equity Research

Pioneer Natural (PXD) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Lower production is expected to have affected Pioneer Natural's (PXD) earnings in Q3.

Zacks Equity Research

Schlumberger (SLB) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Schlumberger (SLB) delivered earnings and revenue surprises of 14.55% and 4.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Linde (LIN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Linde (LIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Is a Beat in the Offing for EQT Corp's (EQT) Q3 Earnings?

by Zacks Equity Research

Higher sales volumes and commodity prices are likely to have aided EQT Corp's (EQT) earnings in Q3.

Zacks Equity Research

Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

SLB or CLB: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

Zacks Equity Research

SLB or CLB: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

by Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

Zacks Equity Research

SLB vs. CLB: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

Zacks Equity Research

SLB or CLB: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SLB vs. CLB: Which Stock Is the Better Value Option?

Zacks Equity Research

Core Labs (CLB) Q2 Earnings Meet Estimates, Sales Narrowly Beat

by Zacks Equity Research

Core Laboratories' (CLB) second-quarter earnings meet the consensus mark, while revenues marginally outperform the same.

Zacks Equity Research

Core Laboratories (CLB) Q2 Earnings Match Estimates

by Zacks Equity Research

Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 0.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline

by Zacks Equity Research

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Implied Volatility Surging for Core Laboratories (CLB) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Core Laboratories (CLB) stock based on the movements in the options market lately.

Zacks Equity Research

Core Laboratories (CLB) Up 2.6% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Core Labs (CLB) Stock Down 3% Since Q1 Earnings & Sales Beat

by Zacks Equity Research

Core Laboratories' (CLB) stock down 3% since the company's first-quarter earnings and revenues beat estimates.

Zacks Equity Research

Core Laboratories (CLB) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Core Laboratories (CLB) delivered earnings and revenue surprises of 33.33% and 3.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is a Surprise Coming for Core Laboratories (CLB) This Earnings Season?

by Zacks Equity Research

Core Laboratories (CLB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

by Zacks Equity Research

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.